ELVN - Company ID 0001672619
As of 2026-11-06, Enliven Therapeutics, Inc. (ELVN) has a market capitalization of $3.56 B, making it the #1655 most valuable US-listed company.
| Date | Market cap |
|---|---|
| 2026-11-06 | $3.56 B |
| 2026-11-05 | $3.30 B |
| 2026-11-04 | $3.46 B |
| 2026-11-03 | $3.34 B |
| 2026-11-02 | $3.27 B |
| 2026-11-01 | $2.70 B |
| 2026-10-31 | $2.70 B |
| 2026-10-30 | $2.70 B |
| 2026-10-29 | $2.75 B |
| 2026-10-28 | $2.73 B |
| 2026-10-27 | $2.66 B |
| 2026-10-26 | $2.51 B |
As of 2026-11-06, Enliven Therapeutics, Inc. (ELVN) has a market capitalization of $3.56 B, making it the #1655 most valuable US-listed company.
Enliven Therapeutics, Inc. is the #1655 largest US-listed company by market capitalization.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| 2026-10-25 | $2.53 B |
| 2026-10-24 | $2.53 B |
| 2026-10-23 | $2.53 B |
| 2026-10-22 | $2.55 B |
| 2026-10-21 | $2.55 B |
| 2026-10-20 | $2.51 B |
| 2026-10-19 | $2.36 B |
| 2026-10-18 | $2.27 B |
| 2026-10-17 | $2.27 B |
| 2026-10-16 | $2.27 B |
| 2026-10-15 | $2.40 B |
| 2026-10-14 | $2.37 B |
| 2026-10-13 | $2.41 B |
| 2026-10-12 | $2.49 B |
| 2026-10-11 | $2.50 B |
| 2026-10-10 | $2.50 B |
| 2026-10-09 | $2.51 B |
| 2026-10-08 | $2.47 B |
Readings accumulate daily as market data refreshes, combining SEC-reported share counts with live prices.